EntrepreneurialCheck
Carl-Emil Grøn Fuglesang estimated net worth profile

Carl-Emil Grøn Fuglesang net worth

Carl-Emil Grøn Fuglesang Net Worth 2026 (Estimated) · Founder at Reshape Biotech · YC W21
est. wealth $18.67M

Quick answer

Carl-Emil Grøn Fuglesang's estimated net worth is $18.67M (range $13.07M – $28.0M) as of 2026. Carl-Emil Grøn Fuglesang is Founder at Reshape Biotech. Reshape Biotech valuation.

Carl-Emil Grøn Fuglesang is Founder at Reshape Biotech (YC W21). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameCarl-Emil Grøn Fuglesang
RoleFounder
CompanyReshape Biotech
YC batchW21
Est. company val$200.0M
Assumed ownership9.3%
Est. paper wealth / net worth$18.67M
$13.07M – $28.0M
  • Company status: Active
  • Education: Master's degree in Biochemistry
  • Region: Denmark
  • Industries: Healthcare, Industrial Bio
  • Team size: 40
  • Website: http://reshapebiotech.com/

Who is Carl-Emil Grøn Fuglesang?

Carl-Emil Grøn Fuglesang is a co-founder of Reshape Biotech, a company participating in Y Combinator's Winter 2021 batch.

Highlights:

  • University of Copenhagen
  • Technical University of Denmark
  • Y Combinator W21

About Reshape Biotech

Reshape Biotech builds lab robots that automate the everyday tasks of microbiologists, from filling plates to analyzing images. Other companies try to sell “one lab robot that does everything”. But those robots become so complicated that they sit unused on the shelf. We build one robot for each function, which makes them easy to use.

FAQ: Carl-Emil Grøn Fuglesang net worth and Reshape Biotech valuation

What is Carl-Emil Grøn Fuglesang's net worth?

Carl-Emil Grøn Fuglesang's estimated net worth is $18.67M (range $13.07M – $28.0M) as of 2026. Carl-Emil Grøn Fuglesang is Founder at Reshape Biotech. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is Reshape Biotech valuation?

Reshape Biotech's estimated valuation on Entrepreneurial Check is $200.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is Carl-Emil Grøn Fuglesang's role?

Carl-Emil Grøn Fuglesang is Founder at Reshape Biotech, a Y Combinator-backed startup (batch W21).